Modified peptides and their uses

Details Modified peptides and their uses Modified peptides and their uses

2007-11-19

2010-06-22

Carlson, Karen Cochrane (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000

Reexamination Certificate

active

07741279

ABSTRACT:
A modified pro-α chain comprising a triple helix forming domain linked to at least an N-terminal domain, the N-terminal domain containing a polypeptide from at least part of a laminin glycoprotein or secretory leukocyte protease inhibitor. The pro-α chain may form part of a procollagen molecule that has the N-terminal domain retained. The procollagen molecule may be incorporated into collagen polymers, matrices and gels and be used for such applications as wound healing.

REFERENCES:
patent: 5266328 (1993-11-01), Skubitz et al.
patent: 6277600 (2001-08-01), Tomita et al.
patent: 0 704 532 (1996-04-01), None
patent: 0 747 068 (1996-12-01), None
patent: 0 985 732 (2000-03-01), None
patent: 1 234 581 (2002-08-01), None
patent: WO 99/08311 (1999-02-01), None
patent: WO 01/64031 (2001-09-01), None
patent: WO 03/035692 (2003-05-01), None

Affiliated with

Also associated with

Rating

Modified peptides and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified peptides and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified peptides and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4182455